Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion type Assertion NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_head.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion description "[However, the clinical relevance of 14-3-3? in hepatocellular carcinoma (HCC) tumor progression and modulation and pathway elucidation remain unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_provenance.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion evidence source_evidence_literature NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_provenance.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion SIO_000772 24923353 NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_provenance.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion wasDerivedFrom befree-20150227 NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_provenance.
- NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_assertion wasGeneratedBy ECO_0000203 NP430778.RA_naTSZwjifkoXIctGYWPZJsPtp2lNW0vhsG2lwJH_G0130_provenance.